These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 29290524)

  • 1. Proximal migration of a subcutaneous contraceptive device resulting in neuropathy.
    Benjamin MA; Radhakrishnan S
    Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():199-200. PubMed ID: 29290524
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-Acting Reversible Contraception.
    J Midwifery Womens Health; 2018 Jul; 63(4):499-500. PubMed ID: 29999231
    [No Abstract]   [Full Text] [Related]  

  • 3. [Contraception for young women with focus on long-acting, reversible contraceptives].
    Ravn P; Petersen KR
    Ugeskr Laeger; 2017 Nov; 179(23):. PubMed ID: 29139352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung migration of contraceptive Implanon NXT.
    Carlos-Alves M; Gomes M; Abreu R; Pinheiro P
    BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31296626
    [No Abstract]   [Full Text] [Related]  

  • 5. Temporal Trends in the Uptake and Continuation of the Etonogestrel Implant in a Large Private Practice Setting.
    Howard DL; Ford A; Ceballos S; Volker KW
    J Womens Health (Larchmt); 2018 Feb; 27(2):191-195. PubMed ID: 28976797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Acting Reversible Contraception: A Primer for the Primary Care Pediatrician.
    Fernandez S
    Pediatr Ann; 2017 Mar; 46(3):e79-e82. PubMed ID: 28287679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postpartum contraception: initiation and effectiveness in a large universal healthcare system.
    Brunson MR; Klein DA; Olsen CH; Weir LF; Roberts TA
    Am J Obstet Gynecol; 2017 Jul; 217(1):55.e1-55.e9. PubMed ID: 28257962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathy associated with etonogestrel implant insertion.
    Brown M; Britton J
    Contraception; 2012 Nov; 86(5):591-3. PubMed ID: 22770789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-acting reversible contraception: a review in special populations.
    Prescott GM; Matthews CM
    Pharmacotherapy; 2014 Jan; 34(1):46-59. PubMed ID: 24130075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder.
    Matusiewicz AK; Melbostad HS; Heil SH
    Contraception; 2017 Nov; 96(5):365-369. PubMed ID: 28778423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intravascular migration of a contraceptive implant].
    de Vries SM; van der Linden PJQ; Huisman MA
    Ned Tijdschr Geneeskd; 2021 Feb; 165():. PubMed ID: 33651491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
    Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
    Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound appearances of Implanon implanted contraceptive devices.
    McNeill G; Ward E; Halpenny D; Snow A; Torreggiani W
    JBR-BTR; 2009; 92(5):259-60. PubMed ID: 19999332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-year continuation of intrauterine devices and contraceptive implants in a mixed-payer setting: a retrospective review.
    Sanders JN; Turok DK; Gawron LM; Law A; Wen L; Lynen R
    Am J Obstet Gynecol; 2017 Jun; 216(6):590.e1-590.e8. PubMed ID: 28188772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmural migration and perforation of a levonorgestrel intrauterine system: a case report and review of the literature.
    Ferguson CA; Costescu D; Jamieson MA; Jong L
    Contraception; 2016 Jan; 93(1):81-6. PubMed ID: 26386445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of long-acting reversible contraceptives to reduce the rate of teen pregnancy.
    Rome E
    Cleve Clin J Med; 2015 Nov; 82(11 Suppl 1):S8-12. PubMed ID: 26555813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reversible long-duration contraceptives: an efficient strategy to reduce non-planned pregnancies].
    Lira-Plascencia J; Velázquez-Ramírez N; Ibargüengoitia-Ochoa F; Montoya-Romero Jde J; Castelazo-Morales E; Valerio-Castro E
    Ginecol Obstet Mex; 2013 Sep; 81(9):530-40. PubMed ID: 24187817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indication of a contraceptive method to a teenager: subcutaneous implant of gestagen].
    Arribas Mir L; Duarte Vallejo S; Saavedra Ruiz A
    Aten Primaria; 2004 Nov; 34(9):499-503. PubMed ID: 15563789
    [No Abstract]   [Full Text] [Related]  

  • 19. Difficult implant removals.
    Voedisch A; Hugin M
    Curr Opin Obstet Gynecol; 2017 Dec; 29(6):449-457. PubMed ID: 28938375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness of a long-acting reversible contraceptive (Implanon) relative to oral contraception in a community setting.
    Lipetz C; Phillips CJ; Fleming CF
    Contraception; 2009 Apr; 79(4):304-9. PubMed ID: 19272500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.